Afrezza

MannKind: Afrezza Delayed Again
TheStreet.com
Tue, 05/10/11 - 10:28 am
MannKind
Afrezza
inhaled insulin
diabetes
Mannkind Denied Again by FDA; Investors Should Consider Generex
Seeking Alpha
Wed, 04/13/11 - 07:55 am
inhaled insulin
MannKind
FDA
Generex
Afrezza
Yet Another Step Back For MannKind
Pharmalot
Mon, 04/11/11 - 12:40 pm
diabetes
MannKind
inhaled insulin
Afrezza
Pending FDA Approval Means Mannkind Is Down, But It's Not Out
Seeking Alpha
Thu, 03/3/11 - 08:49 am
FDA
inhaled insulin
MannKind
Afrezza
Earnings Setback for MannKind: Frozen in Tracks Over Afrezza?
Seeking Alpha
Tue, 02/15/11 - 09:24 am
earnings
MannKind
Afrezza
inhaled insulin
Is It Worth Buying the MannKind Dip?
Seeking Alpha
Sun, 02/13/11 - 10:57 am
MannKind
Afrezza
inhaled insulin
MannKind Shares Plunged: What You Need to Know
Motley Fool
Sat, 02/12/11 - 12:18 pm
MannKind
Afrezza
inhaled insulin
diabetes
Mannkind Shares Popped: What You Need to Know
Motley Fool
Wed, 02/2/11 - 05:22 pm
Afrezza
inhaled insulin
MannKind
5 Drugmakers Headed Back to the Drawing Board
Motley Fool
Mon, 01/31/11 - 06:54 pm
Bydureon
Eli Lilly
Amylin
diabetes
MannKind
Afrezza
InterMune
Esbriet
IPF
Lorqess
Arena Pharmaceuticals
Vivus
Qnexa
Inhaled Insulin Maker Still Breathing - MannKind’s future may hinge on deep pockets of owner
LA Business Journal, CA
Tue, 01/25/11 - 12:03 pm
MannKind
inhaled insulin
diabetes
Afrezza
MannKind’s Inhaled Insulin Fails to Win U.S. Approval
Bloomberg
Thu, 01/20/11 - 09:47 am
inhaled insulin
MannKind
Afrezza
diabetes
Mann doubles down on biotech as Afrezza decision looms
Fierce Biotech
Wed, 01/5/11 - 11:49 am
diabetes
MannKind
inhaled insulin
Afrezza
FDA Delay of MannKind's Inhaled Insulin Is Mostly Positive News
Seeking Alpha
Thu, 12/30/10 - 11:12 am
MannKind
FDA
Afrezza
inhaled insulin
FDA Delay Could Be Very Bad Omen For MannKind
Forbes
Tue, 12/28/10 - 03:59 pm
FDA
MannKind
inhaled insulin
Afrezza
MannKind Says FDA Will Take Another Four Weeks on Insulin Decision
WSJ Online
Tue, 12/28/10 - 01:08 pm
FDA
inhaled insulin
MannKind
Afrezza
Will the FDA Be Kind to MannKind?
Motley Fool
Wed, 12/22/10 - 04:36 pm
FDA
MannKind
inhaled insulin
Afrezza
Three Upcoming Make-or-Break Biotech Approvals
Seeking Alpha
Sun, 12/19/10 - 11:22 am
Vertex Pharmaceuticals
Telaprevir
Merck
hepatitis C
cystic fibrosis
Human Genome Sciences
Benlysta
lupus
MannKind
Afrezza
inhaled insulin
MannKind Shares Plunged: What You Need to Know
Motley Fool
Thu, 12/16/10 - 12:48 pm
MannKind
Afrezza
insulin
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Mon, 12/13/10 - 12:26 pm
MannKind
Afrezza
Alimera
pSivida
Seattle Genetics
brentuximab vedotin
Illuvien
AstraZeneca
Zictifa
Clinical Data
Vilazodone
Orexigen
Contrave
Bristol-Myers Squibb
Yervoy
Pfizer
Protalix BioTherapeutics
UPLYSO
Xiafaxan
Salix
Human Genome Sciences
Benlysta
Dendreon
Provenge
InterMune
Esbriet
Cell Therapeutics
pixantrone
Forest Labs
Daxas
MELA Sciences
MelaFind
XenoPort
GSK
Horizant
Spectrum Pharmaceuticals
Fusilev
Adventrx
Vertex Pharmaceuticals
Telaprevir
Neutral on MannKind
Yahoo/Zacks
Sat, 12/11/10 - 11:39 am
MannKind
Afrezza
inhaled insulin
diabetes

Pages